Cellectar Biosciences Stock Price History
CLRB Stock | USD 5.23 0.24 4.81% |
Below is the normalized historical share price chart for Cellectar Biosciences extending back to June 14, 2005. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cellectar Biosciences stands at 5.23, as last reported on the 21st of July, with the highest price reaching 5.45 and the lowest price hitting 4.99 during the day.
If you're considering investing in Cellectar Stock, it is important to understand the factors that can impact its price. Cellectar Biosciences secures Sharpe Ratio (or Efficiency) of -0.0278, which signifies that the company had a -0.0278 % return per unit of risk over the last 3 months. Cellectar Biosciences exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cellectar Biosciences' Standard Deviation of 11.09, risk adjusted performance of (0.02), and Mean Deviation of 6.05 to double-check the risk estimate we provide.
At present, Cellectar Biosciences' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 274.2 M, whereas Total Stockholder Equity is forecasted to decline to about 8.9 M. . The current year's Price To Sales Ratio is expected to grow to -1,046. In addition to that, Price Earnings Ratio is expected to decline to -0.26. Cellectar Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of November 2005 | 200 Day MA 20.8597 | 50 Day MA 7.9108 | Beta 0.521 |
Cellectar | Build AI portfolio with Cellectar Stock |
Sharpe Ratio = -0.0278
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | CLRB |
Estimated Market Risk
11.32 actual daily | 96 96% of assets are less volatile |
Expected Return
-0.31 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cellectar Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cellectar Biosciences by adding Cellectar Biosciences to a well-diversified portfolio.
Cellectar Biosciences Stock Price History Chart
There are several ways to analyze Cellectar Stock price data. The simplest method is using a basic Cellectar candlestick price chart, which shows Cellectar Biosciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | June 4, 2025 | 13.85 |
Lowest Price | July 8, 2025 | 4.7 |
Cellectar Biosciences July 21, 2025 Stock Price Synopsis
Various analyses of Cellectar Biosciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cellectar Stock. It can be used to describe the percentage change in the price of Cellectar Biosciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cellectar Stock.Cellectar Biosciences Price Rate Of Daily Change | 1.05 | |
Cellectar Biosciences Accumulation Distribution | 11,077 | |
Cellectar Biosciences Price Action Indicator | 0.13 | |
Cellectar Biosciences Price Daily Balance Of Power | 0.52 |
Cellectar Biosciences July 21, 2025 Stock Price Analysis
Cellectar Stock Price History Data
The price series of Cellectar Biosciences for the period between Tue, Apr 22, 2025 and Mon, Jul 21, 2025 has a statistical range of 9.15 with a coefficient of variation of 27.53. The prices are distributed with arithmetic mean of 8.07. The median price for the last 90 days is 7.92. The company had 1:30 stock split on 24th of June 2025. Cellectar Biosciences issued dividends on 2018-07-17.Open | High | Low | Close | Volume | ||
07/21/2025 | 4.99 | 5.45 | 4.99 | 5.23 | 131,236 | |
07/21/2025 | 4.99 | 5.45 | 4.99 | 5.23 | 131,236 | |
07/18/2025 | 4.98 | 5.07 | 4.89 | 4.99 | 54,242 | |
07/17/2025 | 5.04 | 5.33 | 4.97 | 4.97 | 114,383 | |
07/16/2025 | 4.90 | 5.30 | 4.88 | 5.04 | 156,666 | |
07/15/2025 | 4.91 | 4.95 | 4.74 | 4.78 | 71,636 | |
07/14/2025 | 4.95 | 5.02 | 4.81 | 4.98 | 53,505 | |
07/11/2025 | 4.96 | 5.05 | 4.80 | 4.88 | 61,394 | |
07/10/2025 | 4.80 | 5.05 | 4.74 | 4.93 | 53,554 | |
07/09/2025 | 4.70 | 4.99 | 4.70 | 4.85 | 118,917 | |
07/08/2025 | 4.62 | 4.86 | 4.62 | 4.70 | 118,265 | |
07/07/2025 | 4.68 | 4.91 | 4.65 | 4.80 | 135,085 | |
07/03/2025 | 5.17 | 5.17 | 4.61 | 4.80 | 238,953 | |
07/02/2025 | 4.86 | 5.07 | 4.60 | 4.73 | 211,057 | |
07/01/2025 | 5.28 | 5.40 | 4.36 | 4.86 | 860,924 | |
06/30/2025 | 8.02 | 8.05 | 7.11 | 7.11 | 129,444 | |
06/27/2025 | 7.03 | 8.30 | 7.03 | 7.90 | 118,577 | |
06/26/2025 | 7.75 | 8.19 | 6.50 | 7.38 | 331,206 | |
06/25/2025 | 9.31 | 10.19 | 7.60 | 7.94 | 276,184 | |
06/24/2025 | 8.55 | 9.85 | 8.30 | 9.70 | 179,613 | |
06/23/2025 | 9.00 | 9.25 | 8.41 | 8.93 | 76,541 | |
06/20/2025 | 9.99 | 10.80 | 8.70 | 8.75 | 128,103 | |
06/18/2025 | 10.35 | 12.00 | 10.35 | 10.97 | 72,708 | |
06/17/2025 | 11.40 | 11.93 | 10.37 | 10.54 | 80,524 | |
06/16/2025 | 11.65 | 12.13 | 11.29 | 11.47 | 65,570 | |
06/13/2025 | 12.60 | 13.47 | 12.15 | 12.40 | 94,763 | |
06/12/2025 | 12.60 | 13.95 | 12.30 | 13.11 | 193,607 | |
06/11/2025 | 12.00 | 13.20 | 11.45 | 12.80 | 492,681 | |
06/10/2025 | 10.80 | 11.70 | 10.53 | 10.98 | 162,166 | |
06/09/2025 | 10.50 | 11.40 | 9.65 | 10.65 | 232,059 | |
06/06/2025 | 11.70 | 12.09 | 10.29 | 10.82 | 299,261 | |
06/05/2025 | 13.16 | 13.72 | 10.67 | 12.24 | 1,333,646 | |
06/04/2025 | 12.77 | 20.60 | 11.70 | 13.85 | 20,870,200 | |
06/03/2025 | 8.10 | 8.76 | 7.84 | 8.33 | 38,178 | |
06/02/2025 | 7.68 | 7.96 | 7.65 | 7.86 | 23,519 | |
05/30/2025 | 7.95 | 7.95 | 7.44 | 7.65 | 7,129 | |
05/29/2025 | 7.37 | 8.01 | 7.34 | 7.92 | 37,629 | |
05/28/2025 | 7.65 | 7.65 | 7.23 | 7.37 | 23,318 | |
05/27/2025 | 7.53 | 7.63 | 7.25 | 7.59 | 38,015 | |
05/23/2025 | 7.53 | 7.75 | 7.26 | 7.47 | 11,600 | |
05/22/2025 | 7.50 | 7.62 | 7.20 | 7.56 | 12,177 | |
05/21/2025 | 8.22 | 8.22 | 7.30 | 7.47 | 19,101 | |
05/20/2025 | 7.62 | 8.00 | 7.53 | 7.92 | 35,151 | |
05/19/2025 | 7.28 | 7.78 | 7.28 | 7.67 | 20,358 | |
05/16/2025 | 7.47 | 7.73 | 7.25 | 7.35 | 20,528 | |
05/15/2025 | 7.23 | 7.67 | 7.21 | 7.61 | 24,551 | |
05/14/2025 | 7.32 | 7.32 | 6.90 | 7.22 | 40,163 | |
05/13/2025 | 8.03 | 8.10 | 7.20 | 7.20 | 47,738 | |
05/12/2025 | 7.88 | 7.92 | 7.43 | 7.92 | 15,145 | |
05/09/2025 | 7.49 | 7.73 | 7.36 | 7.42 | 9,614 | |
05/08/2025 | 7.50 | 7.86 | 7.33 | 7.55 | 17,671 | |
05/07/2025 | 7.20 | 7.40 | 7.05 | 7.33 | 14,095 | |
05/06/2025 | 7.71 | 7.92 | 7.20 | 7.22 | 33,379 | |
05/05/2025 | 8.22 | 8.37 | 7.70 | 7.98 | 24,899 | |
05/02/2025 | 8.07 | 8.22 | 7.50 | 8.12 | 40,624 | |
05/01/2025 | 7.74 | 8.03 | 7.61 | 7.93 | 12,033 | |
04/30/2025 | 8.40 | 8.40 | 7.20 | 7.55 | 68,302 | |
04/29/2025 | 8.93 | 9.02 | 8.43 | 8.73 | 37,553 | |
04/28/2025 | 9.02 | 9.23 | 8.73 | 8.89 | 24,560 | |
04/25/2025 | 9.51 | 9.60 | 9.05 | 9.30 | 13,234 | |
04/24/2025 | 9.34 | 9.42 | 8.92 | 9.39 | 11,625 |
About Cellectar Biosciences Stock history
Cellectar Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cellectar is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cellectar Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cellectar Biosciences stock prices may prove useful in developing a viable investing in Cellectar Biosciences
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 37.1 M | 39 M | |
Net Loss | -25.7 M | -24.5 M |
Cellectar Biosciences Stock Technical Analysis
Cellectar Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
All Next | Launch Module |
Cellectar Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cellectar Biosciences' price direction in advance. Along with the technical and fundamental analysis of Cellectar Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cellectar to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.02) | |||
Jensen Alpha | (0.48) | |||
Total Risk Alpha | (1.89) | |||
Treynor Ratio | (0.32) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Cellectar Stock analysis
When running Cellectar Biosciences' price analysis, check to measure Cellectar Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectar Biosciences is operating at the current time. Most of Cellectar Biosciences' value examination focuses on studying past and present price action to predict the probability of Cellectar Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectar Biosciences' price. Additionally, you may evaluate how the addition of Cellectar Biosciences to your portfolios can decrease your overall portfolio volatility.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |